These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31177454)

  • 1. Oncolytic Activity of the Vaccine Strain of Type 3 Poliovirus on the Model of Rat Glioma C6 Cells.
    Sosnovtseva AO; Zheltukhin AO; Lipatova AV; Chumakov PM; Chekhonin VP
    Bull Exp Biol Med; 2019 May; 167(1):111-115. PubMed ID: 31177454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity of C6 Glioma Cells Carrying the Human Poliovirus Receptor to Oncolytic Polioviruses.
    Sosnovtseva AO; Lipatova AV; Grinenko NF; Baklaushev VP; Chumakov PM; Chekhonin VP
    Bull Exp Biol Med; 2016 Oct; 161(6):821-825. PubMed ID: 27783287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncolytic Virotherapy for the Treatment of Malignant Glioma.
    Foreman PM; Friedman GK; Cassady KA; Markert JM
    Neurotherapeutics; 2017 Apr; 14(2):333-344. PubMed ID: 28265902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Oncolytic properties of some orthopoxviruses, adenoviruses and parvoviruses in human glioma cells].
    Razumov IA; Sviatchenko VA; Protopopova EV; Kochneva GV; Kiselev NN; Gubanova NV; Shilov AG; Mordvinov VA; Netesov SV; Chumakov PM; Loktev VB
    Vestn Ross Akad Med Nauk; 2013; (12):4-8. PubMed ID: 24741936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The alpha/beta interferon response controls tissue tropism and pathogenicity of poliovirus.
    Ida-Hosonuma M; Iwasaki T; Yoshikawa T; Nagata N; Sato Y; Sata T; Yoneyama M; Fujita T; Taya C; Yonekawa H; Koike S
    J Virol; 2005 Apr; 79(7):4460-9. PubMed ID: 15767446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour-specific triple-regulated oncolytic herpes virus to target glioma.
    Delwar ZM; Liu G; Kuo Y; Lee C; Bu L; Rennie PS; Jia WW
    Oncotarget; 2016 May; 7(19):28658-69. PubMed ID: 27070093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon Beta and Interferon Alpha 2a Differentially Protect Head and Neck Cancer Cells from Vesicular Stomatitis Virus-Induced Oncolysis.
    Westcott MM; Liu J; Rajani K; D'Agostino R; Lyles DS; Porosnicu M
    J Virol; 2015 Aug; 89(15):7944-54. PubMed ID: 25995245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-Attenuated Clone of Virulent Semliki Forest Virus Overcomes Antiviral Type I Interferon in Resistant Mouse CT-2A Glioma.
    Martikainen M; Niittykoski M; von und zu Fraunberg M; Immonen A; Koponen S; van Geenen M; Vähä-Koskela M; Ylösmäki E; Jääskeläinen JE; Saksela K; Hinkkanen A
    J Virol; 2015 Oct; 89(20):10637-47. PubMed ID: 26269187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune Checkpoint Blockade, Immunogenic Chemotherapy or IFN-α Blockade Boost the Local and Abscopal Effects of Oncolytic Virotherapy.
    Fend L; Yamazaki T; Remy C; Fahrner C; Gantzer M; Nourtier V; Préville X; Quéméneur E; Kepp O; Adam J; Marabelle A; Pitt JM; Kroemer G; Zitvogel L
    Cancer Res; 2017 Aug; 77(15):4146-4157. PubMed ID: 28536278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Oncolytic viruses for therapy of malignant glioma].
    Sosnovtceva AO; Grinenko NF; Lipatova AV; Chumakov PM; Chekhonin VP
    Biomed Khim; 2016 May; 62(4):376-90. PubMed ID: 27562991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virus.
    Kirn DH; Wang Y; Le Boeuf F; Bell J; Thorne SH
    PLoS Med; 2007 Dec; 4(12):e353. PubMed ID: 18162040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncolytic viral therapy of malignant glioma.
    Parker JN; Bauer DF; Cody JJ; Markert JM
    Neurotherapeutics; 2009 Jul; 6(3):558-69. PubMed ID: 19560745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poliovirus receptor CD155-targeted oncolysis of glioma.
    Merrill MK; Bernhardt G; Sampson JH; Wikstrand CJ; Bigner DD; Gromeier M
    Neuro Oncol; 2004 Jul; 6(3):208-17. PubMed ID: 15279713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL.
    Kazimirsky G; Jiang W; Slavin S; Ziv-Av A; Brodie C
    Stem Cell Res Ther; 2016 Oct; 7(1):149. PubMed ID: 27724977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncolytic immunotherapy through tumor-specific translation and cytotoxicity of poliovirus.
    Brown MC; Gromeier M
    Discov Med; 2015 May; 19(106):359-65. PubMed ID: 26105699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncolytic treatment and cure of neuroblastoma by a novel attenuated poliovirus in a novel poliovirus-susceptible animal model.
    Toyoda H; Yin J; Mueller S; Wimmer E; Cello J
    Cancer Res; 2007 Mar; 67(6):2857-64. PubMed ID: 17363609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncolytic Adenovirus and Tumor-Targeting Immune Modulatory Therapy Improve Autologous Cancer Vaccination.
    Jiang H; Rivera-Molina Y; Gomez-Manzano C; Clise-Dwyer K; Bover L; Vence LM; Yuan Y; Lang FF; Toniatti C; Hossain MB; Fueyo J
    Cancer Res; 2017 Jul; 77(14):3894-3907. PubMed ID: 28566332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncolytic virus-derived type I interferon restricts CAR T cell therapy.
    Evgin L; Huff AL; Wongthida P; Thompson J; Kottke T; Tonne J; Schuelke M; Ayasoufi K; Driscoll CB; Shim KG; Reynolds P; Monie DD; Johnson AJ; Coffey M; Young SL; Archer G; Sampson J; Pulido J; Perez LS; Vile R
    Nat Commun; 2020 Jun; 11(1):3187. PubMed ID: 32581235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncolytic virotherapy for human bone and soft tissue sarcomas using live attenuated poliovirus.
    Atsumi S; Matsumine A; Toyoda H; Niimi R; Iino T; Nakamura T; Matsubara T; Asanuma K; Komada Y; Uchida A; Sudo A
    Int J Oncol; 2012 Sep; 41(3):893-902. PubMed ID: 22692919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newcastle diseases virus strain V4UPM displayed oncolytic ability against experimental human malignant glioma.
    Zulkifli MM; Ibrahim R; Ali AM; Aini I; Jaafar H; Hilda SS; Alitheen NB; Abdullah JM
    Neurol Res; 2009 Feb; 31(1):3-10. PubMed ID: 18937888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.